Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses.

Li XC, Zand MS, Li Y, Zheng XX, Strom TB.

J Immunol. 1998 Sep 1;161(5):2241-7.

PMID:
9725217
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Th1 to Th2 immune deviation facilitates, but does not cause, islet allograft tolerance in mice.

Zhang D, Sanchez-Fueyo A, Kawamoto K, Alexopoulos SP, Zhang W, Zheng XX.

Cytokine. 2010 Sep;51(3):311-9. doi: 10.1016/j.cyto.2010.06.007. Epub 2010 Jul 2.

PMID:
20598563
[PubMed - indexed for MEDLINE]
3.

Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.

Barbara JA, Turvey SE, Kingsley CI, Spriewald BM, Hara M, Witzke O, Morris PJ, Wood KJ.

Transplantation. 2000 Dec 15;70(11):1641-9.

PMID:
11152227
[PubMed - indexed for MEDLINE]
4.

The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH.

Diabetes. 2002 Nov;51(11):3202-10.

PMID:
12401711
[PubMed - indexed for MEDLINE]
Free Article
5.

Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.

Simeonovic CJ, Townsend MJ, Karupiah G, Wilson JD, Zarb JC, Mann DA, Young IG.

Cell Transplant. 1999 Jul-Aug;8(4):365-73.

PMID:
10478716
[PubMed - indexed for MEDLINE]
6.

Impact of interleukin-2-expanded regulatory T cells in various allogeneic combinations on mouse skin graft survival.

Vokaer B, Charbonnier LM, Lemaître PH, Le Moine A.

Transplant Proc. 2012 Nov;44(9):2840-4. doi: 10.1016/j.transproceed.2012.09.032.

PMID:
23146537
[PubMed - indexed for MEDLINE]
7.

Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.

Simeonovic CJ, Brown DJ, Townsend MJ, Wilson JD.

Cell Transplant. 1996 Sep-Oct;5(5):525-41.

PMID:
8889212
[PubMed - indexed for MEDLINE]
8.

MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.

Wang M, Racine J, Zhang M, Wu T, Deng R, Johnston H, Shen C, Siswanto K, Zeng D.

J Immunol. 2014 Aug 15;193(4):2005-15. doi: 10.4049/jimmunol.1401137. Epub 2014 Jul 7.

PMID:
25000982
[PubMed - indexed for MEDLINE]
9.

MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.

Yamada J, Hamuro J, Fukushima A, Ohteki T, Terai K, Iwakura Y, Yagita H, Kinoshita S.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2139-46. doi: 10.1167/iovs.08-2993. Epub 2009 Jan 10.

PMID:
19136699
[PubMed - indexed for MEDLINE]
Free Article
10.

Xenoreactive CD4+ memory T cells resist inhibition by anti-CD44 mAb and reject islet grafts via a Th2-dependent pathway.

Peng Y, Chen J, Shao W, Wang F, Dai H, Cheng P, Xia J, Wang F, Huang R, Zhu Q, Qi Z.

Xenotransplantation. 2011 Jul-Aug;18(4):252-61. doi: 10.1111/j.1399-3089.2011.00646.x.

PMID:
21848543
[PubMed - indexed for MEDLINE]
11.

Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.

Boisgérault F, Liu Y, Anosova N, Ehrlich E, Dana MR, Benichou G.

J Immunol. 2001 Aug 15;167(4):1891-9.

PMID:
11489968
[PubMed - indexed for MEDLINE]
Free Article
12.

IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts.

Cunnusamy K, Niederkorn JY.

Am J Transplant. 2013 Dec;13(12):3076-84. doi: 10.1111/ajt.12466. Epub 2013 Oct 1.

PMID:
24119152
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.

Yang DF, Qiu WH, Zhu HF, Lei P, Wen X, Dai H, Zhou W, Shen GX.

Transpl Immunol. 2008 Jul;19(3-4):197-201. doi: 10.1016/j.trim.2008.05.005. Epub 2008 Jun 17.

PMID:
18667318
[PubMed - indexed for MEDLINE]
14.

Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.

Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF.

Cell Transplant. 1999 Jul-Aug;8(4):375-81.

PMID:
10478717
[PubMed - indexed for MEDLINE]
16.

MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

Kupfer TM, Crawford ML, Pham K, Gill RG.

J Immunol. 2005 Aug 15;175(4):2309-16.

PMID:
16081800
[PubMed - indexed for MEDLINE]
Free Article
17.

Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.

Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG.

J Immunol. 2000 Apr 1;164(7):3627-34.

PMID:
10725719
[PubMed - indexed for MEDLINE]
Free Article
18.

Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants.

Fedoseyeva EV, Kishimoto K, Rolls HK, Illigens BM, Dong VM, Valujskikh A, Heeger PS, Sayegh MH, Benichou G.

J Immunol. 2002 Aug 1;169(3):1168-74.

PMID:
12133936
[PubMed - indexed for MEDLINE]
Free Article
19.

CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.

Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB.

J Immunol. 1999 Apr 15;162(8):4983-90.

PMID:
10202046
[PubMed - indexed for MEDLINE]
Free Article
20.

A major role for host MHC class I antigen presentation for promoting islet allograft survival.

Beilke J, Johnson Z, Kuhl N, Gill RG.

Transplant Proc. 2004 May;36(4):1173-4.

PMID:
15194406
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk